The reiteration of a Buy rating and maintenance of a $7 price target by a reputable analyst firm like Canaccord Genuity is likely to instill confidence among investors and could positively influence Taysha Gene Therapies' stock price in the short term. Analyst ratings, especially from well-regarded firms, often have a significant impact on how stocks are perceived in the market.